RecruitingNCT05014399
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Sponsor
Joseph McCollom
Enrollment
60 participants
Start Date
Sep 20, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this research study is to see how the brain changes in patients receiving chemotherapy (cytotoxic drug) treatment for colon or rectal cancer at Parkview Cancer Institute. This information will be used to identify helpful tests to diagnose individuals at risk for developing difficulties with thinking and memory due to their cancer treatments.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Signed written informed consent must be obtained and documented according to International Conference on Harmonisation (ICH)- Good Clinical Practice (GCP), the local regulatory requirements, and permission to use private health information in accordance with the Health Insurance Portability and Accountability Act (HIPAA) prior to study-specific screening procedures. Must be able to provide study-specific informed consent prior to study entry.
- A histologically-confirmed colorectal tumor
- Patients who will be treated with cytotoxic chemotherapies including Capecitabine, Oxaliplatin, 5 fluorouracil, and Irinotecan are eligible.
- Patients must not have received cytotoxic chemotherapy previous to enrollment.
Exclusion Criteria7
- Prior administration of anti-cancer chemotherapy, radiotherapy, immunotherapy, or investigational agents
- Patients having mental incompetence as assessed by study PI, which would hinder completion of the surveys
- Pregnant or breastfeeding
- Any known brain metastases
- Non-English speaking patients
- Patients who have been diagnosed with any neuro-cognitive disorder including traumatic brain injuries, Alzheimer's disease, Parkinson's disease, Huntington's disease, and Creutzfeldt-Jakob disease.
- Patients deemed inappropriate to participate in this study by the study PI or coordinator will be excluded.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05014399
Related Trials
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer
NCT022908342 locations
Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy
NCT047244991 location
Surviving Daily Life
NCT070547231 location
Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer
NCT0602763225 locations
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
NCT067277731 location